ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Photodynamic Therapy Drugs (PTD) Market Outlook, In‑Depth Analysis & Forecast to 2031
Published Date: November 2025
|
Report Code: QYRE-Auto-14I17192
Home | Market Reports | Health| Nursing
Global Photodynamic Therapy Drugs PTD Market Research Report 2024
BUY CHAPTERS

Global Photodynamic Therapy Drugs (PTD) Market Outlook, In‑Depth Analysis & Forecast to 2031

Code: QYRE-Auto-14I17192
Report
November 2025
Pages:144
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
DUSA Pharmaceuticals
Soligenix Inc
ORALIA
Theralase
Quest PharmaTech
Biofrontera
Merck
QIYUE BIOLOGY
Shanghai Fudan-zhangjiang Bio-Pharmaceutical
ApexBio Technology
Thermo Fisher
Shanghai Guangsheng Pharmaceutical

Photodynamic Therapy Drugs (PTD) Market

The global Photodynamic Therapy Drugs (PTD) market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Photodynamic therapy drugs (PTD) are photosensitizing agents used in photodynamic therapy, a non-invasive medical treatment that involves the administration of light-sensitive drugs followed by exposure to specific wavelengths of light to target and destroy abnormal cells, such as cancer cells or skin lesions.
From a downstream perspective, Pancreatic Cancer accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
Photodynamic Therapy Drugs (PTD) leading manufacturers including DUSA Pharmaceuticals, Soligenix, ORALIA, Theralase, Quest Pharmatech, Biofrontera, Merck, QIYUE BIOLOGY, Shanghai Fudan-Zhangjiang Bio-Pharmaceutical, Shanghai Guangsheng Pharmaceutical, etc., dominate supply; the top five capture approximately % of global revenue, with DUSA Pharmaceuticals leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR  %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Photodynamic Therapy Drugs (PTD) market across value chain. It analyzes historical revenue data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies market size, growth rates, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries, detailing dominant products, competitive landscape, and downstream demand trends.
Critical competitive intelligence profiles players—revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise Industry‑chain overview maps upstream, middlestream, and downstream distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation

Scope of Photodynamic Therapy Drugs (PTD) Market Report

Report Metric Details
Report Name Photodynamic Therapy Drugs (PTD) Market
Segment by Type
  • Aminolevulinic Acid
  • Hemoporfin
  • Sinoporphyrin Sodium
  • Others
Segment by Application
  • Pancreatic Cancer
  • Esophageal Cancer
  • Skin Cancer
  • Lung Cancer
  • Others
Sales by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company DUSA Pharmaceuticals, Soligenix, ORALIA, Theralase, Quest Pharmatech, Biofrontera, Merck, QIYUE BIOLOGY, Shanghai Fudan-Zhangjiang Bio-Pharmaceutical, Shanghai Guangsheng Pharmaceutical, APExBIO Technology, Thermo Fisher
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the Photodynamic Therapy Drugs (PTD) study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
  • Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
  • Chapter 3: Dissects the player landscape—ranks by revenue and profitability, details Player performance by product type and evaluates concentration alongside M&A moves.
  • Chapter 4: Unlocks high margin product segments—compares revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
  • Chapter 5: Targets downstream market opportunities—evaluates market size by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
  • Chapter 6: North America—breaks down market size by Type, by Application and country, profiles key players and assesses growth drivers and barriers.
  • Chapter 7: Europe—analyses regional market by Type, by Application and players, flagging drivers and barriers.
  • Chapter 8: Asia Pacific—quantifies market size by Type, by Application, and region/country, profiles top players, and uncovers high potential expansion areas.
  • Chapter 9: Central & South America—measures market size by Type, by Application, and country, profiles top players, and identifies investment opportunities and challenges.
  • Chapter 10: Middle East and Africa—evaluates market size by Type, by Application, and country, profiles key players, and outlines investment prospects and market hurdles
  • Chapter 11: Profiles players in depth—details product specs, revenue, margins; Top-tier players 2024 sales breakdowns by Product type, by Application, by region SWOT analysis, and recent strategic developments.
  • Chapter 12: Industry chain—analyses upstream, cost drivers, plus downstream channels.
  • Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
  • Chapter 14: Actionable conclusions and strategic recommendations.
  • Why This Report:
  • Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
  • Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
  • Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.
  • Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
  • Capitalize on the projected billion‑dollar opportunity with data‑driven regional and segment tactics (Chapter 12-14).
  • Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

Who are the main players in the Photodynamic Therapy Drugs (PTD) Market report?

Ans: The main players in the Photodynamic Therapy Drugs (PTD) Market are DUSA Pharmaceuticals, Soligenix, ORALIA, Theralase, Quest Pharmatech, Biofrontera, Merck, QIYUE BIOLOGY, Shanghai Fudan-Zhangjiang Bio-Pharmaceutical, Shanghai Guangsheng Pharmaceutical, APExBIO Technology, Thermo Fisher

What are the Application segmentation covered in the Photodynamic Therapy Drugs (PTD) Market report?

Ans: The Applications covered in the Photodynamic Therapy Drugs (PTD) Market report are Pancreatic Cancer, Esophageal Cancer, Skin Cancer, Lung Cancer, Others

What are the Type segmentation covered in the Photodynamic Therapy Drugs (PTD) Market report?

Ans: The Types covered in the Photodynamic Therapy Drugs (PTD) Market report are Aminolevulinic Acid, Hemoporfin, Sinoporphyrin Sodium, Others

1 Study Coverage
1.1 Introduction to Photodynamic Therapy Drugs (PTD): Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Photodynamic Therapy Drugs (PTD) Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Aminolevulinic Acid
1.2.3 Hemoporfin
1.2.4 Sinoporphyrin Sodium
1.2.5 Others
1.3 Market Segmentation by Application
1.3.1 Global Photodynamic Therapy Drugs (PTD) Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Pancreatic Cancer
1.3.3 Esophageal Cancer
1.3.4 Skin Cancer
1.3.5 Lung Cancer
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Photodynamic Therapy Drugs (PTD) Revenue Estimates and Forecasts 2020-2031
2.2 Global Photodynamic Therapy Drugs (PTD) Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020-2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.2.4 Emerging Market Focus: Growth Drivers & Investment Trends
3 Competition by Players
3.1 Global Photodynamic Therapy Drugs (PTD) Player Revenue Rankings and Profitability
3.1.1 Global Revenue (Value) by Players (2020-2025)
3.1.2 Global Key Player Revenue Ranking (2023 vs. 2024)
3.1.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.1.4 Gross Margin by Top Player (2020 VS 2024)
3.2 Global Photodynamic Therapy Drugs (PTD) Companies Headquarters and Service Footprint
3.3 Main Product Type Market Size by Players
3.3.1 Aminolevulinic Acid Market Size by Players
3.3.2 Hemoporfin Market Size by Players
3.3.3 Sinoporphyrin Sodium Market Size by Players
3.3.4 Others Market Size by Players
3.4 Global Photodynamic Therapy Drugs (PTD) Market Concentration and Dynamics
3.4.1 Global Market Concentration (CR5 and HHI)
3.4.2 Entrant/Exit Impact Analysis
3.4.3 Strategic Moves: M&A, Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Photodynamic Therapy Drugs (PTD) Revenue Trends by Type
4.1.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.1.2 Global Revenue Market Share by Type (2020-2031)
4.2 Key Product Attributes and Differentiation
4.3 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.3.1 High-Growth Niches and Adoption Drivers
4.3.2 Profitability Hotspots and Cost Drivers
4.3.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Photodynamic Therapy Drugs (PTD) Revenue by Application
5.1.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.1.2 Revenue Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Downstream Customer Analysis
5.2.1 Top Customers by Region
5.2.2 Top Customers by Application
6 North America
6.1 North America Market Size (2020-2031)
6.2 North America Key Players Revenue in 2024
6.3 North America Photodynamic Therapy Drugs (PTD) Market Size by Type (2020-2031)
6.4 North America Photodynamic Therapy Drugs (PTD) Market Size by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Photodynamic Therapy Drugs (PTD) Market Size by Country
6.6.1 North America Revenue Trends by Country
6.6.2 US
6.6.3 Canada
6.6.4 Mexico
7 Europe
7.1 Europe Market Size (2020-2031)
7.2 Europe Key Players Revenue in 2024
7.3 Europe Photodynamic Therapy Drugs (PTD) Market Size by Type (2020-2031)
7.4 Europe Photodynamic Therapy Drugs (PTD) Market Size by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Photodynamic Therapy Drugs (PTD) Market Size by Country
7.6.1 Europe Revenue Trends by Country
7.6.2 Germany
7.6.3 France
7.6.4 U.K.
7.6.5 Italy
7.6.6 Russia
8 Asia-Pacific
8.1 Asia-Pacific Market Size (2020-2031)
8.2 Asia-Pacific Key Players Revenue in 2024
8.3 Asia-Pacific Photodynamic Therapy Drugs (PTD) Market Size by Type (2020-2031)
8.4 Asia-Pacific Photodynamic Therapy Drugs (PTD) Market Size by Application (2020-2031)
8.5 Asia-Pacific Growth Accelerators and Market Barriers
8.6 Asia-Pacific Photodynamic Therapy Drugs (PTD) Market Size by Region
8.6.1 Asia-Pacific Revenue Trends by Region
8.7 China
8.8 Japan
8.9 South Korea
8.10 Australia
8.11 India
8.12 Southeast Asia
8.12.1 Indonesia
8.12.2 Vietnam
8.12.3 Malaysia
8.12.4 Philippines
8.12.5 Singapore
9 Central and South America
9.1 Central and South America Market Size (2020-2031)
9.2 Central and South America Key Players Revenue in 2024
9.3 Central and South America Photodynamic Therapy Drugs (PTD) Market Size by Type (2020-2031)
9.4 Central and South America Photodynamic Therapy Drugs (PTD) Market Size by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Photodynamic Therapy Drugs (PTD) Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Market Size (2020-2031)
10.2 Middle East and Africa Key Players Revenue in 2024
10.3 Middle East and Africa Photodynamic Therapy Drugs (PTD) Market Size by Type (2020-2031)
10.4 Middle East and Africa Photodynamic Therapy Drugs (PTD) Market Size by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Photodynamic Therapy Drugs (PTD) Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Israel
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 DUSA Pharmaceuticals
11.1.1 DUSA Pharmaceuticals Corporation Information
11.1.2 DUSA Pharmaceuticals Business Overview
11.1.3 DUSA Pharmaceuticals Photodynamic Therapy Drugs (PTD) Product Features and Attributes
11.1.4 DUSA Pharmaceuticals Photodynamic Therapy Drugs (PTD) Revenue and Gross Margin (2020-2025)
11.1.5 DUSA Pharmaceuticals Photodynamic Therapy Drugs (PTD) Revenue by Product in 2024
11.1.6 DUSA Pharmaceuticals Photodynamic Therapy Drugs (PTD) Revenue by Application in 2024
11.1.7 DUSA Pharmaceuticals Photodynamic Therapy Drugs (PTD) Revenue by Geographic Area in 2024
11.1.8 DUSA Pharmaceuticals Photodynamic Therapy Drugs (PTD) SWOT Analysis
11.1.9 DUSA Pharmaceuticals Recent Developments
11.2 Soligenix
11.2.1 Soligenix Corporation Information
11.2.2 Soligenix Business Overview
11.2.3 Soligenix Photodynamic Therapy Drugs (PTD) Product Features and Attributes
11.2.4 Soligenix Photodynamic Therapy Drugs (PTD) Revenue and Gross Margin (2020-2025)
11.2.5 Soligenix Photodynamic Therapy Drugs (PTD) Revenue by Product in 2024
11.2.6 Soligenix Photodynamic Therapy Drugs (PTD) Revenue by Application in 2024
11.2.7 Soligenix Photodynamic Therapy Drugs (PTD) Revenue by Geographic Area in 2024
11.2.8 Soligenix Photodynamic Therapy Drugs (PTD) SWOT Analysis
11.2.9 Soligenix Recent Developments
11.3 ORALIA
11.3.1 ORALIA Corporation Information
11.3.2 ORALIA Business Overview
11.3.3 ORALIA Photodynamic Therapy Drugs (PTD) Product Features and Attributes
11.3.4 ORALIA Photodynamic Therapy Drugs (PTD) Revenue and Gross Margin (2020-2025)
11.3.5 ORALIA Photodynamic Therapy Drugs (PTD) Revenue by Product in 2024
11.3.6 ORALIA Photodynamic Therapy Drugs (PTD) Revenue by Application in 2024
11.3.7 ORALIA Photodynamic Therapy Drugs (PTD) Revenue by Geographic Area in 2024
11.3.8 ORALIA Photodynamic Therapy Drugs (PTD) SWOT Analysis
11.3.9 ORALIA Recent Developments
11.4 Theralase
11.4.1 Theralase Corporation Information
11.4.2 Theralase Business Overview
11.4.3 Theralase Photodynamic Therapy Drugs (PTD) Product Features and Attributes
11.4.4 Theralase Photodynamic Therapy Drugs (PTD) Revenue and Gross Margin (2020-2025)
11.4.5 Theralase Photodynamic Therapy Drugs (PTD) Revenue by Product in 2024
11.4.6 Theralase Photodynamic Therapy Drugs (PTD) Revenue by Application in 2024
11.4.7 Theralase Photodynamic Therapy Drugs (PTD) Revenue by Geographic Area in 2024
11.4.8 Theralase Photodynamic Therapy Drugs (PTD) SWOT Analysis
11.4.9 Theralase Recent Developments
11.5 Quest Pharmatech
11.5.1 Quest Pharmatech Corporation Information
11.5.2 Quest Pharmatech Business Overview
11.5.3 Quest Pharmatech Photodynamic Therapy Drugs (PTD) Product Features and Attributes
11.5.4 Quest Pharmatech Photodynamic Therapy Drugs (PTD) Revenue and Gross Margin (2020-2025)
11.5.5 Quest Pharmatech Photodynamic Therapy Drugs (PTD) Revenue by Product in 2024
11.5.6 Quest Pharmatech Photodynamic Therapy Drugs (PTD) Revenue by Application in 2024
11.5.7 Quest Pharmatech Photodynamic Therapy Drugs (PTD) Revenue by Geographic Area in 2024
11.5.8 Quest Pharmatech Photodynamic Therapy Drugs (PTD) SWOT Analysis
11.5.9 Quest Pharmatech Recent Developments
11.6 Biofrontera
11.6.1 Biofrontera Corporation Information
11.6.2 Biofrontera Business Overview
11.6.3 Biofrontera Photodynamic Therapy Drugs (PTD) Product Features and Attributes
11.6.4 Biofrontera Photodynamic Therapy Drugs (PTD) Revenue and Gross Margin (2020-2025)
11.6.5 Biofrontera Recent Developments
11.7 Merck
11.7.1 Merck Corporation Information
11.7.2 Merck Business Overview
11.7.3 Merck Photodynamic Therapy Drugs (PTD) Product Features and Attributes
11.7.4 Merck Photodynamic Therapy Drugs (PTD) Revenue and Gross Margin (2020-2025)
11.7.5 Merck Recent Developments
11.8 QIYUE BIOLOGY
11.8.1 QIYUE BIOLOGY Corporation Information
11.8.2 QIYUE BIOLOGY Business Overview
11.8.3 QIYUE BIOLOGY Photodynamic Therapy Drugs (PTD) Product Features and Attributes
11.8.4 QIYUE BIOLOGY Photodynamic Therapy Drugs (PTD) Revenue and Gross Margin (2020-2025)
11.8.5 QIYUE BIOLOGY Recent Developments
11.9 Shanghai Fudan-Zhangjiang Bio-Pharmaceutical
11.9.1 Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Corporation Information
11.9.2 Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Business Overview
11.9.3 Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Photodynamic Therapy Drugs (PTD) Product Features and Attributes
11.9.4 Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Photodynamic Therapy Drugs (PTD) Revenue and Gross Margin (2020-2025)
11.9.5 Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Recent Developments
11.10 Shanghai Guangsheng Pharmaceutical
11.10.1 Shanghai Guangsheng Pharmaceutical Corporation Information
11.10.2 Shanghai Guangsheng Pharmaceutical Business Overview
11.10.3 Shanghai Guangsheng Pharmaceutical Photodynamic Therapy Drugs (PTD) Product Features and Attributes
11.10.4 Shanghai Guangsheng Pharmaceutical Photodynamic Therapy Drugs (PTD) Revenue and Gross Margin (2020-2025)
11.10.5 Company Ten Recent Developments
11.11 APExBIO Technology
11.11.1 APExBIO Technology Corporation Information
11.11.2 APExBIO Technology Business Overview
11.11.3 APExBIO Technology Photodynamic Therapy Drugs (PTD) Product Features and Attributes
11.11.4 APExBIO Technology Photodynamic Therapy Drugs (PTD) Revenue and Gross Margin (2020-2025)
11.11.5 APExBIO Technology Recent Developments
11.12 Thermo Fisher
11.12.1 Thermo Fisher Corporation Information
11.12.2 Thermo Fisher Business Overview
11.12.3 Thermo Fisher Photodynamic Therapy Drugs (PTD) Product Features and Attributes
11.12.4 Thermo Fisher Photodynamic Therapy Drugs (PTD) Revenue and Gross Margin (2020-2025)
11.12.5 Thermo Fisher Recent Developments
12 Photodynamic Therapy Drugs (PTD)Industry Chain Analysis
12.1 Photodynamic Therapy Drugs (PTD) Industry Chain
12.2 Upstream Analysis
12.2.1 Upstream Key Suppliers
12.3 Middlestream Analysis
12.4 Downstream Sales Model and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Photodynamic Therapy Drugs (PTD) Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Photodynamic Therapy Drugs (PTD) Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
FEATURED COMPANIES
DUSA Pharmaceuticals
Soligenix Inc
ORALIA
Theralase
Quest PharmaTech
Biofrontera
Merck
QIYUE BIOLOGY
Shanghai Fudan-zhangjiang Bio-Pharmaceutical
ApexBio Technology
Thermo Fisher
Shanghai Guangsheng Pharmaceutical
List of Tables
 Table 1. Global Photodynamic Therapy Drugs (PTD) Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Table 2. Global Photodynamic Therapy Drugs (PTD) Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Table 3. Global Photodynamic Therapy Drugs (PTD) Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 4. Global Photodynamic Therapy Drugs (PTD) Revenue by Region (2020-2025) & (US$ Million)
 Table 5. Global Photodynamic Therapy Drugs (PTD) Revenue by Region (2026-2031) & (US$ Million)
 Table 6. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 7. Global Photodynamic Therapy Drugs (PTD) Revenue by Players (2020-2025) & (US$ Million)
 Table 8. Global Photodynamic Therapy Drugs (PTD) Revenue Market Share by Players (2020-2025)
 Table 9. Global Key Players’Ranking Shift (2023 vs. 2024) (Based on Revenue)
 Table 10. Global Photodynamic Therapy Drugs (PTD) by Player Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Photodynamic Therapy Drugs (PTD) as of 2024)
 Table 11. Global Photodynamic Therapy Drugs (PTD) Average Gross Margin (%) by Player (2020 VS 2024)
 Table 12. Global Photodynamic Therapy Drugs (PTD) Companies Headquarters
 Table 13. Global Photodynamic Therapy Drugs (PTD) Market Concentration Ratio (CR5 and HHI)
 Table 14. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
 Table 15. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
 Table 16. Global Photodynamic Therapy Drugs (PTD) Revenue by Type (2020-2025) & (US$ Million)
 Table 17. Global Photodynamic Therapy Drugs (PTD) Revenue by Type (2026-2031) & (US$ Million)
 Table 18. Key Product Attributes and Differentiation
 Table 19. Global Photodynamic Therapy Drugs (PTD) Revenue by Application (2020-2025) & (US$ Million)
 Table 20. Global Photodynamic Therapy Drugs (PTD) Revenue by Application (2026-2031) & (US$ Million)
 Table 21. Photodynamic Therapy Drugs (PTD) High-Growth Sectors Demand CAGR (2024-2031)
 Table 22. Top Customers by Region
 Table 23. Top Customers by Application
 Table 24. North America Photodynamic Therapy Drugs (PTD) Growth Accelerators and Market Barriers
 Table 25. North America Photodynamic Therapy Drugs (PTD) Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 26. Europe Photodynamic Therapy Drugs (PTD) Growth Accelerators and Market Barriers
 Table 27. Europe Photodynamic Therapy Drugs (PTD) Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 28. Asia-Pacific Photodynamic Therapy Drugs (PTD) Growth Accelerators and Market Barriers
 Table 29. Asia-Pacific Photodynamic Therapy Drugs (PTD) Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 30. Central and South America Photodynamic Therapy Drugs (PTD) Investment Opportunities and Key Challenges
 Table 31. Central and South America Photodynamic Therapy Drugs (PTD) Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 32. Middle East and Africa Photodynamic Therapy Drugs (PTD) Investment Opportunities and Key Challenges
 Table 33. Middle East and Africa Photodynamic Therapy Drugs (PTD) Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 34. DUSA Pharmaceuticals Corporation Information
 Table 35. DUSA Pharmaceuticals Description and Major Businesses
 Table 36. DUSA Pharmaceuticals Product Features and Attributes
 Table 37. DUSA Pharmaceuticals Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 38. DUSA Pharmaceuticals Revenue Proportion by Product in 2024
 Table 39. DUSA Pharmaceuticals Revenue Proportion by Application in 2024
 Table 40. DUSA Pharmaceuticals Revenue Proportion by Geographic Area in 2024
 Table 41. DUSA Pharmaceuticals Photodynamic Therapy Drugs (PTD) SWOT Analysis
 Table 42. DUSA Pharmaceuticals Recent Developments
 Table 43. Soligenix Corporation Information
 Table 44. Soligenix Description and Major Businesses
 Table 45. Soligenix Product Features and Attributes
 Table 46. Soligenix Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 47. Soligenix Revenue Proportion by Product in 2024
 Table 48. Soligenix Revenue Proportion by Application in 2024
 Table 49. Soligenix Revenue Proportion by Geographic Area in 2024
 Table 50. Soligenix Photodynamic Therapy Drugs (PTD) SWOT Analysis
 Table 51. Soligenix Recent Developments
 Table 52. ORALIA Corporation Information
 Table 53. ORALIA Description and Major Businesses
 Table 54. ORALIA Product Features and Attributes
 Table 55. ORALIA Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 56. ORALIA Revenue Proportion by Product in 2024
 Table 57. ORALIA Revenue Proportion by Application in 2024
 Table 58. ORALIA Revenue Proportion by Geographic Area in 2024
 Table 59. ORALIA Photodynamic Therapy Drugs (PTD) SWOT Analysis
 Table 60. ORALIA Recent Developments
 Table 61. Theralase Corporation Information
 Table 62. Theralase Description and Major Businesses
 Table 63. Theralase Product Features and Attributes
 Table 64. Theralase Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 65. Theralase Revenue Proportion by Product in 2024
 Table 66. Theralase Revenue Proportion by Application in 2024
 Table 67. Theralase Revenue Proportion by Geographic Area in 2024
 Table 68. Theralase Photodynamic Therapy Drugs (PTD) SWOT Analysis
 Table 69. Theralase Recent Developments
 Table 70. Quest Pharmatech Corporation Information
 Table 71. Quest Pharmatech Description and Major Businesses
 Table 72. Quest Pharmatech Product Features and Attributes
 Table 73. Quest Pharmatech Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 74. Quest Pharmatech Revenue Proportion by Product in 2024
 Table 75. Quest Pharmatech Revenue Proportion by Application in 2024
 Table 76. Quest Pharmatech Revenue Proportion by Geographic Area in 2024
 Table 77. Quest Pharmatech Photodynamic Therapy Drugs (PTD) SWOT Analysis
 Table 78. Quest Pharmatech Recent Developments
 Table 79. Biofrontera Corporation Information
 Table 80. Biofrontera Description and Major Businesses
 Table 81. Biofrontera Product Features and Attributes
 Table 82. Biofrontera Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 83. Biofrontera Recent Developments
 Table 84. Merck Corporation Information
 Table 85. Merck Description and Major Businesses
 Table 86. Merck Product Features and Attributes
 Table 87. Merck Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 88. Merck Recent Developments
 Table 89. QIYUE BIOLOGY Corporation Information
 Table 90. QIYUE BIOLOGY Description and Major Businesses
 Table 91. QIYUE BIOLOGY Product Features and Attributes
 Table 92. QIYUE BIOLOGY Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 93. QIYUE BIOLOGY Recent Developments
 Table 94. Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Corporation Information
 Table 95. Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Description and Major Businesses
 Table 96. Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Product Features and Attributes
 Table 97. Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 98. Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Recent Developments
 Table 99. Shanghai Guangsheng Pharmaceutical Corporation Information
 Table 100. Shanghai Guangsheng Pharmaceutical Description and Major Businesses
 Table 101. Shanghai Guangsheng Pharmaceutical Product Features and Attributes
 Table 102. Shanghai Guangsheng Pharmaceutical Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 103. Shanghai Guangsheng Pharmaceutical Recent Developments
 Table 104. APExBIO Technology Corporation Information
 Table 105. APExBIO Technology Description and Major Businesses
 Table 106. APExBIO Technology Product Features and Attributes
 Table 107. APExBIO Technology Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 108. APExBIO Technology Recent Developments
 Table 109. Thermo Fisher Corporation Information
 Table 110. Thermo Fisher Description and Major Businesses
 Table 111. Thermo Fisher Product Features and Attributes
 Table 112. Thermo Fisher Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 113. Thermo Fisher Recent Developments
 Table 114. Raw Materials Key Suppliers
 Table 115. Distributors List
 Table 116. Market Trends and Market Evolution
 Table 117. Market Drivers and Opportunities
 Table 118. Market Challenges, Risks, and Restraints
 Table 119. Research Programs/Design for This Report
 Table 120. Key Data Information from Secondary Sources
 Table 121. Key Data Information from Primary Sources


List of Figures
 Figure 1. Photodynamic Therapy Drugs (PTD) Product Picture
 Figure 2. Global Photodynamic Therapy Drugs (PTD) Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. Aminolevulinic Acid Product Picture
 Figure 4. Hemoporfin Product Picture
 Figure 5. Sinoporphyrin Sodium Product Picture
 Figure 6. Others Product Picture
 Figure 7. Global Photodynamic Therapy Drugs (PTD) Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 8. Pancreatic Cancer
 Figure 9. Esophageal Cancer
 Figure 10. Skin Cancer
 Figure 11. Lung Cancer
 Figure 12. Others
 Figure 13. Photodynamic Therapy Drugs (PTD) Report Years Considered
 Figure 14. Global Photodynamic Therapy Drugs (PTD) Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 15. Global Photodynamic Therapy Drugs (PTD) Revenue (2020-2031) & (US$ Million)
 Figure 16. Global Photodynamic Therapy Drugs (PTD) Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Figure 17. Global Photodynamic Therapy Drugs (PTD) Revenue Market Share by Region (2020-2031)
 Figure 18. Global Photodynamic Therapy Drugs (PTD) Revenue Market Share Ranking (2024)
 Figure 19. Tier Distribution by Revenue Contribution (2020 VS 2024)
 Figure 20. Aminolevulinic Acid Revenue Market Share by Player in 2024
 Figure 21. Hemoporfin Revenue Market Share by Player in 2024
 Figure 22. Sinoporphyrin Sodium Revenue Market Share by Player in 2024
 Figure 23. Others Revenue Market Share by Player in 2024
 Figure 24. Global Photodynamic Therapy Drugs (PTD) Revenue Market Share by Type (2020-2031)
 Figure 25. Global Photodynamic Therapy Drugs (PTD) Revenue Market Share by Application (2020-2031)
 Figure 26. North America Photodynamic Therapy Drugs (PTD) Revenue YoY (2020-2031) & (US$ Million)
 Figure 27. North America Top 5 Players Photodynamic Therapy Drugs (PTD) Revenue (US$ Million) in 2024
 Figure 28. North America Photodynamic Therapy Drugs (PTD) Revenue (US$ Million) by Type (2020 - 2031)
 Figure 29. North America Photodynamic Therapy Drugs (PTD) Revenue (US$ Million) by Application (2020-2031)
 Figure 30. US Photodynamic Therapy Drugs (PTD) Revenue (2020-2031) & (US$ Million)
 Figure 31. Canada Photodynamic Therapy Drugs (PTD) Revenue (2020-2031) & (US$ Million)
 Figure 32. Mexico Photodynamic Therapy Drugs (PTD) Revenue (2020-2031) & (US$ Million)
 Figure 33. Europe Photodynamic Therapy Drugs (PTD) Revenue YoY (2020-2031) & (US$ Million)
 Figure 34. Europe Top 5 Players Photodynamic Therapy Drugs (PTD) Revenue (US$ Million) in 2024
 Figure 35. Europe Photodynamic Therapy Drugs (PTD) Revenue (US$ Million) by Type (2020-2031)
 Figure 36. Europe Photodynamic Therapy Drugs (PTD) Revenue (US$ Million) by Application (2020-2031)
 Figure 37. Germany Photodynamic Therapy Drugs (PTD) Revenue (2020-2031) & (US$ Million)
 Figure 38. France Photodynamic Therapy Drugs (PTD) Revenue (2020-2031) & (US$ Million)
 Figure 39. U.K. Photodynamic Therapy Drugs (PTD) Revenue (2020-2031) & (US$ Million)
 Figure 40. Italy Photodynamic Therapy Drugs (PTD) Revenue (2020-2031) & (US$ Million)
 Figure 41. Russia Photodynamic Therapy Drugs (PTD) Revenue (2020-2031) & (US$ Million)
 Figure 42. Asia-Pacific Photodynamic Therapy Drugs (PTD) Revenue YoY (2020-2031) & (US$ Million)
 Figure 43. Asia-Pacific Top 8 Players Photodynamic Therapy Drugs (PTD) Revenue (US$ Million) in 2024
 Figure 44. Asia-Pacific Photodynamic Therapy Drugs (PTD) Revenue (US$ Million) by Type (2020-2031)
 Figure 45. Asia-Pacific Photodynamic Therapy Drugs (PTD) Revenue (US$ Million) by Application (2020-2031)
 Figure 46. Indonesia Photodynamic Therapy Drugs (PTD) Revenue (2020-2031) & (US$ Million)
 Figure 47. Japan Photodynamic Therapy Drugs (PTD) Revenue (2020-2031) & (US$ Million)
 Figure 48. South Korea Photodynamic Therapy Drugs (PTD) Revenue (2020-2031) & (US$ Million)
 Figure 49. Australia Photodynamic Therapy Drugs (PTD) Revenue (2020-2031) & (US$ Million)
 Figure 50. India Photodynamic Therapy Drugs (PTD) Revenue (2020-2031) & (US$ Million)
 Figure 51. Indonesia Photodynamic Therapy Drugs (PTD) Revenue (2020-2031) & (US$ Million)
 Figure 52. Vietnam Photodynamic Therapy Drugs (PTD) Revenue (2020-2031) & (US$ Million)
 Figure 53. Malaysia Photodynamic Therapy Drugs (PTD) Revenue (2020-2031) & (US$ Million)
 Figure 54. Philippines Photodynamic Therapy Drugs (PTD) Revenue (2020-2031) & (US$ Million)
 Figure 55. Singapore Photodynamic Therapy Drugs (PTD) Revenue (2020-2031) & (US$ Million)
 Figure 56. Central and South America Photodynamic Therapy Drugs (PTD) Revenue YoY (2020-2031) & (US$ Million)
 Figure 57. Central and South America Top 5 Players Photodynamic Therapy Drugs (PTD) Revenue (US$ Million) in 2024
 Figure 58. Central and South America Photodynamic Therapy Drugs (PTD) Revenue (US$ Million) by Type (2020-2031)
 Figure 59. Central and South America Photodynamic Therapy Drugs (PTD) Revenue (US$ Million) by Application (2020-2031)
 Figure 60. Brazil Photodynamic Therapy Drugs (PTD) Revenue (2020-2025) & (US$ Million)
 Figure 61. Argentina Photodynamic Therapy Drugs (PTD) Revenue (2020-2025) & (US$ Million)
 Figure 62. Middle East and Africa Photodynamic Therapy Drugs (PTD) Revenue YoY (2020-2031) & (US$ Million)
 Figure 63. Middle East and Africa Top 5 Players Photodynamic Therapy Drugs (PTD) Revenue (US$ Million) in 2024
 Figure 64. South America Photodynamic Therapy Drugs (PTD) Revenue (US$ Million) by Type (2020-2031)
 Figure 65. Middle East and Africa Photodynamic Therapy Drugs (PTD) Revenue (US$ Million) by Application (2020-2031)
 Figure 66. GCC Countries Photodynamic Therapy Drugs (PTD) Revenue (2020-2025) & (US$ Million)
 Figure 67. Israel Photodynamic Therapy Drugs (PTD) Revenue (2020-2025) & (US$ Million)
 Figure 68. Egypt Photodynamic Therapy Drugs (PTD) Revenue (2020-2025) & (US$ Million)
 Figure 69. South Africa Photodynamic Therapy Drugs (PTD) Revenue (2020-2025) & (US$ Million)
 Figure 70. Photodynamic Therapy Drugs (PTD) Industry Chain Mapping
 Figure 71. Channels of Distribution (Direct Vs Distribution)
 Figure 72. Bottom-up and Top-down Approaches for This Report
 Figure 73. Data Triangulation
 Figure 74. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Seventh Sense AI

SIMILAR REPORTS

Global Photosensitizers for Photodynamic Therapy Market Research Report 2024
Global Photodynamic Therapy Device Market Research Report 2024
Global Photodynamic Laser Therapy Market Research Report 2024
Global Photodynamic Therapy Implantable Device Market Research Report 2024
Global Wireless PDT Implant Market Research Report 2024
Global Photochemotherapy Market Research Report 2024
Global Red and Blue Photodynamic Therapy Instrument Market Research Report 2024
Global Malignancy Photosensitizers Market Research Report 2024
Liposomal Verteporfin Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Semiconductor Laser Photodynamic Therapy Machine Market Research Report 2024
Global Blue Light Treatment Market Research Report 2024
LED Photodynamic Therapy Apparatus Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Cancer Photodynamic Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Photosensitive Antibacterial Drug Market Research Report 2024
Global Photodynamic Therapy Market Insights Forecast to 2030
Ophthalmic Lasers Therapeutic Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Intravenous Laser Photodynamic Therapy Market Research Report 2024
Global Portable Laser Therapy Device Market Research Report 2024
Global Endovenous Laser Photodynamic Therapy Market Research Report 2024
Global Porphyrias Drugs Market Research Report 2024

RELATED REPORTS

Global Life Sciences IT Market Outlook, In‑Depth Analysis & Forecast to 2031

120 Pages
Type: Report
Code: QYRE-Auto-19E17259
Wed Nov 12 00:00:00 UTC 2025

Add to Cart

Global Rehabilitation Evaluation Equipment Market Outlook, In‑Depth Analysis & Forecast to 2031

120 Pages
Type: Report
Code: QYRE-Auto-39U17029
Wed Nov 12 00:00:00 UTC 2025

Add to Cart

Global Modular Healthcare Buildings Market Outlook, In‑Depth Analysis & Forecast to 2031

120 Pages
Type: Report
Code: QYRE-Auto-24Y16719
Wed Nov 12 00:00:00 UTC 2025

Add to Cart

Global Digital Telepathology Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-0S20450
Wed Nov 12 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions